Densityai
by Densitas Inc
510(k) K192973
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK192973 | Date19 Feb 2020 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Official records
From the FDA record
- Received by the FDA
- 24 Oct 2019
- FDA decision
- 19 Feb 2020 (Substantially Equivalent)
- FDA review time
- 118 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Across registries
- FDA 510(k) K192973 decided 19 Feb 2020 Active
- EUDAMED Active
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Full name
- densitas densityai
- 510(k) Number
- FDA product code
- LLZ
- FDA applicant
- Densitas, Inc.
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
Densityai is an AI-powered software tool designed for automated breast density assessment from mammographic images. Classified as a radiological imaging software (Product Code LLZ), it employs deep-learning algorithms to standardize and quantify breast density measurements, reducing variability inherent in visual radiologist interpretation. The device supports clinical decision-making by providing objective, reproducible density classifications aligned with established nomenclature standards. Its output aids in risk stratification and workflow optimization for breast cancer screening programs.
Densityai is supplied as a software application integrated into mammography systems, requiring no additional hardware. It operates in radiology departments and screening centers, processing digital mammograms to generate standardized density scores. The software is intended for single-use per image analysis, with no sterility or reprocessing requirements. Compliance with FDA 510(k) clearance (K192973) and EU MDR ensures its regulatory standing for use in diagnostic imaging workflows. No MRI safety considerations apply, as it is a non-invasive software solution.
Similar devices
Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).
- SYNAPSE 3D NODULE ANALYSIS by Fujifilm Medical System U.S.A., Inc.
- MEDVISION by Evergreen Technologies, Inc.
- SYNGO.VIA WEB VIEWER by Siemens Medi Cal Solutions, Inc.
- DPS-33, 000 WITH CENTOR OPTION by Adac Laboratories
- syngo Application Software 30000267 by Siemens Healthcare GmbH
- MODALIXX by Ampronix, Inc.
- PRO VISION by Algotec Systems, Ltd.
- Konicaminolta DI-X1 by KONICA MINOLTA, INC.
- 3VISEON/SURGERY by 3Mensio Medical Imaging BV
- SMARTSPOT 2000 by CMT Medical Technologies, Ltd.